Patient Rating:

4.7 out of 5

135 Patient Ratings
65 Patient Comments

William Lowrance, M.D., M.P.H.

Patient Rating:

4.7 out of 5

135 Patient Ratings
65 Patient Comments

Clinical Details

Schedule An Appointment Clinical Office Address
(801) 587-4381 Huntsman Cancer Hospital
Clinic 2B, GU
1950 Circle of Hope
Salt Lake City, UT 84112
Map

Bio

William Lowrance, MD, MPH, is an assistant professor in the Division of Urology at the University of Utah School of Medicine and a Huntsman Cancer Institute (HCI) investigator. He specializes in the surgical treatment of urologic malignancies. His practice at the Huntsman Cancer Institute primarily focuses on treating prostate cancer, bladder cancer, kidney cancer, testicular cancer, and penile cancer. He has extensive training and experience with open, laparoscopic, and robotic surgical techniques. His research efforts focus on understanding and improving clinical outcomes for patients with urologic cancers. Dr. Lowrance has published numerous peer-reviewed urologic articles, book chapters, and editorials. He is member of the American Urological Association’s Advanced Prostate Cancer Clinical Guidelines committee and serves on the editorial board for multiple medical journals. He peer reviews medical manuscripts for over 10 different medical journals. Additionally, he has received a National Institutes of Health Challenge grant for studying the differences between open and robotic radical prostatectomy.

Board Certification and Academic Information

Academic Departments Surgery - Assistant Professor
Academic Divisions Urology
Board Certification American Board of Urology
Cancer Center Programs Cancer Control & Population Sciences

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Likelihood of recommending care provider
4.7
My confidence in care provider
4.7
Time care provider spent with me
4.6
Care provider spoke using clear language
4.7
Care provider's effort to include me in decisions
4.7
Care provider's concern for questions & worries
4.7
Care provider's explanation of condition/problem
4.7
Wait time at clinic
4.1
Care provider's friendliness and courtesy
4.8

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

July 31, 2014

Dr. Lowrance had a pretty mediocre bedside manner. I did a bit of research online and he was described as very caring and warm, so I might have caught him on an off day.

July 16, 2014

i felt like i was on a production belt - not a unique person

July 03, 2014

excellent care

July 03, 2014

Overall good experience for bad situation.

June 16, 2014

One hour wait, is way to long. Please think of my time also.

June 15, 2014

blood work

June 06, 2014

very good

May 26, 2014

All people I interfaced with were courteous and professional.

May 24, 2014

This is reason I come.

May 18, 2014

All were excellent. Dr. Lowrance was particularly impressive. Really outstanding I thought.

May 10, 2014

Awesome place.

April 26, 2014

Dr. William Lowrance was most informative, thoughtful, and knowledgeable. I was very lucky to have Dr. Lowrance as my doctor.

April 12, 2014

Excellent experience. This was my second appointment at Huntsman. I am very pleased with the care I have received both times.

March 13, 2014

Dr Lowrance is an absolutely outstanding physician and most of all one of the nicest people I ever meet.

February 15, 2014

I truly felt I was in good hands and being cared for by people who really care.

January 20, 2014

good

January 07, 2014

We have no complaints at all about Huntsman staff. It seems as if Huntsman staff is set apart and above, from some other medical institutions that we have been involved in.

January 06, 2014

have let other people know how great our time down here has been

November 18, 2013

This is the best care provider I have ever been to.

November 13, 2013

Everything else were great except Q.4. I felt at times I was not included.

October 29, 2013

Dr Lowrance is the best!

October 21, 2013

Unable to tell me why I am experiencing the symptoms that I am. Focused only on the cancer.

October 21, 2013

Dr. Lowrance exceeded my expectations for an academic specialist.

September 24, 2013

The Care Provider stayed through the whole prcedure

September 23, 2013

Dr. Lawrance and staff are really a great bunch of individuals, they care about what they are doing.

September 22, 2013

Never were we rushed or cut short. The care is above and beyond !

August 17, 2013

very nice and informative

July 16, 2013

Way to long to wait in the exam room

July 09, 2013

this clinic is seriously overbooked.

July 07, 2013

felt that the staff was concerned and engaged

June 24, 2013

Everyone involved provided excellent care, information, and treatment.

June 18, 2013

it was a good experience all together

June 17, 2013

felt better about things when we left had some issues explained and set our mind at ease

June 04, 2013

I was quite relieved and satisfied with what I was told. The visual of my CT scan was educational and I like being treated like an educated adult.

May 22, 2013

All my experience was very positive from beginning to end, I talked to very acknowledgeable, intelligent, caring people.

April 21, 2013

the doctor was very informative about helping us make the decisions we needed to make.

April 09, 2013

great experince

April 08, 2013

Fell very confident in Dr Lowrence.

March 18, 2013

I feel that I have always been treated with courtesy and thoughtful concern. There are not many bright spots in dealing with cancer...there are indeed very few. But being at the Huntsman is one of those bright moments. I am grateful to have access to the Huntsman Cancer Institute.

March 16, 2013

Impressed with how well the staff cared about each person involved.

February 21, 2013

Y'know, when you're told that you don't have cancer, it's pretty hard to say anything bad about your visit.

February 20, 2013

I was nervous about going to a different doctor and treatment center. However, after arriving I was treated courteously and respectfully. I appreciate it.

February 11, 2013

Dr. Lowrance explained the going-forward treatment options and answered all questions for both my wife and I. Patrick the resident, was also very informative.

January 30, 2013

Dr. LOWRANCE is extremely gentle & caring. He is AWESOME!

January 21, 2013

Dr. Lowrance was excellent!

January 07, 2013

Very good

January 01, 2013

The attending physicians and the assisting personnel were excellent. They introduced themselves and were genuine in their efforts to assist me through the process.

December 31, 2012

Good experience

December 30, 2012

Very good. I would recommend this facility and the staff to everyone!

December 18, 2012

I would like to have spent more time, which is probably common. The time I had was sufficient. I realize the doctor has other patients to see.

December 10, 2012

we love Dr. Lowrance. he has been so helpful and willing to discuss anything and making sure we understand and that we do not have any questions

December 05, 2012

I can't say enough good about your staff they do a wonderful job. I highly recommend your facility to others. We have been ask often where they should go my family and myself explain in detail why they should go to your facility.

November 19, 2012

god experience

November 07, 2012

Outstanding medical professionals!

October 14, 2012

Outstanding care and direction

October 10, 2012

liked how doctor explained everything well

October 08, 2012

We feel fortunate to have Dr. Lowrance. Excellent doctor.

October 02, 2012

Dr Lowrance was superior in all aspects

August 21, 2012

Dr Lowrence was excellent

March 24, 2012

All very good!

March 24, 2012

I am very impressed with all providers.

March 17, 2012

Dr. Lowrance is an excellent doctor and I feel very fortunate to be under his care.

March 03, 2012

Really appreciate the time the doctor took to go over the medical history. Spent a lot of time explaining things.

March 03, 2012

They just didn't do what they told us was going to happen. It was postponed to a later surgery date. We felt that this caused us an extra trip to SLC, over 400 miles one way plus overnights.

February 18, 2012

I really appreciated the Dr's expertise and his ability to answer all my questions. I am a professor of physics at UofU with a good understanding of anatomy and biology as well and I greatly appreciated the Dr's detailed responses ultimately in reasonably technical terms that greatly enchanced my understanding of my situation.

Academic Profile

Research Interests

  • Renal Cancer
  • Urothelial Cancer
  • Cancer Clinical Genetics Communication
  • Testicular Cancer
  • Prostate Cancer
  • Cancer Genetics
  • Bladder Cancer
  • Health Services Research
  • Chronic Kidney Disease and Cancer Risk

Board Certification and Academic Information

Academic Departments Surgery - Assistant Professor
Academic Divisions Urology
Board Certification American Board of Urology
Cancer Center Programs Cancer Control & Population Sciences

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 587-4282 Huntsman Cancer Hospital
1950 Circle of Hope
Salt Lake City, UT 84112

Academic Bio

William Lowrance, MD, MPH, is an assistant professor in the Division of Urology at the University of Utah School of Medicine and a Huntsman Cancer Institute (HCI) investigator. Dr. Lowrance is co-leader of the HCI Prostate Disease Oriented Team and a member of the HCI Cancer Control and Population Sciences program. He specializes in the surgical treatment of urologic malignancies. His practice at the Huntsman Cancer Institute primarily focuses on treating prostate cancer, bladder cancer, kidney cancer, testicular cancer, and penile cancer. He has extensive training and experience with open, laparoscopic, and robotic surgical techniques.

His research efforts focus on understanding and improving clinical outcomes for patients with urologic cancers. As a clinical outcomes researcher, he has conducted comparative effectiveness studies of outcomes between robotic and open radical prostatectomy. He also studies the cost and patterns of care, as well as disparities in treatment delivery of various genitourinary malignancies. He is investigating a possible link between chronic kidney disease and renal cancer. In addition to his health services research, he designs and conducts clinical trials studying novel approaches for the treatment of prostate, kidney, and bladder cancer.

Dr. Lowrance has published numerous peer-reviewed urologic articles, book chapters, and editorials. He is member of the American Urological Association’s Advanced Prostate Cancer Clinical Guidelines committee and serves on the editorial board for the medical journals, Urologists in Cancer Care and Frontiers in Genitourinary Oncology. He peer reviews medical manuscripts for over 10 different medical journals. Additionally, he has received a National Institutes of Health Challenge grant for studying the differences between open and robotic radical prostatectomy.

Dr. Lowrance completed his medical degree at the Medical University of South Carolina in Charleston, SC. Following medical school, he completed a General Surgery internship and Urology residency at Vanderbilt University Medical Center in Nashville, TN. He then completed a fellowship in urologic oncology at Memorial Sloan-Kettering Cancer Center in New York, NY. During this time, he also earned a masters degree in public health from Harvard University.

Education

Education History

Type School Degree
Graduate Training Harvard School of Public Health
Summer Program in Clinical Effectiveness
M.P.H.
Fellowship Memorial Sloan-Kettering Cancer Center
Urologic Oncology
Fellow
Chief Resident Vanderbilt University Medical Center
Urology
Chief Resident
Residency Vanderbilt University Medical Center
Urology
Resident
Professional Medical Medical University of South Carolina
Medicine
M.D.
Undergraduate Washington and Lee University
Chemistry, Summa cum laude
B.A.

Publications

Selected Provider Publications

Journal Article

  1. ONeil BB, Preston A, Gannon J, Stephenson RA, Lowrance W, Dechet CB, Tward JD, Myers JB, Brant WO (2014). Climacturia after definitive treatment of prostate cancer. J Urol, 191(1), 159-163.
  2. Myers JB, Taylor MB, Brant WO, Lowrance W, Wallis MC, Presson AP, Morris SE, Nirula R, Stevens MH (2013). Process improvement in trauma: traumatic bladder injuries and compliance with recommended imaging evaluation. J Trauma Acute Care Surg, 74(1), 264-9.
  3. Hardee MJ, Lowrance W, Brant WO, Presson AP, Stevens MH, Myers JB (2013). High grade renal injuries: application of Parkland Hospital predictors of intervention for renal hemorrhage. J Urol, 189(5), 1771-6.
  4. Christensson A, Savage C, Sjoberg DD, Cronin AM, Frank OBrien M, Lowrance W, Nilsson PM, Vickers AJ, Russo P, Lilja H (2013). Association of cancer with moderately impaired renal function at baseline in a large, representative, population-based cohort followed for up to 30 years. Int J Cancer, 133(6), 1452-8.
  5. Corcoran AT, Russo P, Lowrance WT, Asnis-Alibozek A, Libertino JA, Pryma DA, Divgi CR, Uzzo RG (2013). A review of contemporary data on surgically resected renal masses-benign or malignant? Urology, 81(4), 707-13.
  6. Cookson MS, Roth BJ, Dahm P, Engstrom C, Freedland SJ, Hussain M, Lin DW, Lowrance WT, Murad MH, Oh WK, Penson DF, Kibel AS (05/09/2013). Castration-Resistant Prostate Cancer: AUA Guidelines. J Urol, Aug 190(2), 429-38.
  7. Aviva G Asnis-Alibozek, PA-C, Michael J Fine, MD, Paul Russo, MD, Trent McLaughlin, BScPharm, PhD, Eileen M Farrelly, MPH, Norman LaFrance, MD, Lowrance WT, MD, MPH (10/01/2013). Cost of Care for Malignant and Benign Renal Masses. Am J Manag Care, 19(8), 617-624.
  8. ONeil BB, Lowrance WT (2013). Office-based Bladder Tumor Fulguration and Surveillance: Indications and Techniques. Urol Clin North Am.
  9. Hardee MJ, Lowrance W, Stevens MH, Nirula R, Brant WO, Morris SE, Myers JB (2013). Process improvement in trauma: compliance with recommended imaging evaluation in the diagnosis of high-grade renal injuries. J Trauma Acute Care Surg, 74(2), 558-62.
  10. Myers JB, Taylor MB, Brant WO, Lowrance WT, Wallis MC, Presson AP, Morris SE, Nirula R, Stevens MH (2013). Process improvement in trauma: traumatic bladder injuries and compliance with recommended imaging evalutaion. J Trauma Acute Care Surg, jan 2013 7(1), 264-9.
  11. Silberstein JL, Poon SA, Maschino AC, Lowrance WT, Garg T, Herr HWm Donet SM, Dalbagni G, Bochner BH, Sandhu JS (2013). Urinary diversion practice patterns among certifying Americans urologist. J Urol, 189(3), 1042-7.
  12. Lowrance WT, Eastham JA, Savage C, Maschino AC, Laudone VP, Dechet CB, Stephenson RA, Scardino PT, Sandju JS (2012 Apr 11). Contemporary Open and Robotic Radical Prostatectomy Practice Patterns Among Urologist in the United States. J Urol.
  13. Lowrance WT, Southwick A, Maschino AC, Sandhu JS (2012). Contemporary Practice Patterns of Endoscopic Surgical Management for Benign Prostatic Hyperplasia Among Urologists in the United States. J Urol.
  14. Bolenz C, Freedland SJ, Hollenbeck BK, Lotan Y, Lowrance WT, Nelson JB, Hu JC (2012). Costs of Radical Prostatectomy for Prostate Cancer: A Systematic Review. Eur Urol, Sep 5 2012.
  15. Mirkin JN, Lowrance WT, Feifer AH, Mulhall JP, Wastham JE, Elkin EB (2012 April 31). Direct-to-consumer internet promotion of robtoic prostatectomy exhibits varying of information. Health Aff (Millwood).
  16. Lowrance WT, Elkin EB, Yee DS, Feifer A, Ehdaie B, Jacks LM, Atoria CL, Selefsky MJ, Scher HI, Scardino PT, Eastham JA (2012 May). Locally advanced prostate cancer: a population-based study of treatment patterns. BJU Int, 109(9), 1309-1314.
  17. Poon SA Silberstein JL, Savage C, Maschino AC, Lowrance WT, Sandhu JS (2012). Surgical practice patterns for male urinary incontinence: analysis of case logs from certifying American urologist. J Urol, jul 2012(188), 205-10.
  18. Lim A, ONeil B, Heilbrun ME, Dechet C, Lowrance WT (2012). The contemporary role of renal mass biopsy in the management of small renal tumors. Front Oncol, 2012(2), 106.
  19. Feifer A, Savage C, Rayala H, Lowrance W, Gotto G, Sprenkle P, Gupta A, Taylor J, Bernstein M, Adeniran A, Tickoo SK, Reuter VE, Russo P (2011). Prognostic impact of muscular venous branch invasion in localized renal cell carcinoma cases. J Urol, 185(1), 37-42.
  20. Adamy A, Lowrance WT, Yee DS, Chong KT, Bernstein M, Tickoo SK, Coleman JA, Russo P (2011). Renal oncocytosis: management and clinical outcomes. J Urol, 185(3), 795-801.
  21. Feifer AH, Elkin EB, Lowrance WT, Denton B, Jacks L, Yee DS, Coleman JA, Laudone VP, Scardino PT, Eastham JA (2011). Temporal trends and predictors of pelvic lymph node dissection in open or minimally invasive radical prostatectomy.LID - 10.1002/cncr.25981 [doi]. Cancer.
  22. Ehdaie B, Chromecki TF, Lee RK, Lotan Y, Margulis V, Karakiewicz PI, Novara G, Raman JD, Ng C, Lowrance WT, Scherr DS, Shariat SF (2011). Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma. J Urol, 186(1), 66-72.
  23. Yee DS, Ishill NM, Lowrance WT, Herr HW, Elkin EB (2011). Ethnic differences in bladder cancer survival. Urology, 78(3), 544-9.
  24. Lowrance WT, Eastham JA, Yee DS, Laudone VP, Denton B, Scardino PT, Elkin EB (2011). Costs of medical care after open or minimally invasive prostate cancer surgery: A population-based analysis.LID - 10.1002/cncr.26609 [doi]. Cancer.
  25. Ehdaie B, Atoria CL, Gupta A, Feifer A, Lowrance WT, Morris MJ, Scardino PT, Eastham JA, Elkin EB (2011 Nov 9). Androgen deprivation and thromboembolic events in men with prostate cancer surgery. A population-based analysis. Cancer.
  26. Ehdaie B, Maschino A, Shariat SF, Rioja J, Hamitlon RJ, Lowrance WT, Poon SA, Al-Ahmadie HA, Herr HW (2011 Nov 16). Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomy. J Urol, 187(1), 74-9.
  27. Lowrance WT, Thompson RH, Yee DS, Kaag M, Donat SM, Russo P (2010). Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies. BJU Int, 105(1), 16-20.
  28. Yee DS, Lowrance WT, Eastham JA, Maschino AC, Cronin AM, Rabbani F (2010). Long-term follow-up of 3-month neoadjuvant hormone therapy before radical prostatectomy in a randomized trial. BJU Int, 105(2), 185-90.
  29. Lowrance WT, Elkin EB, Scardino PT, Eastham JA (2010). Words of wisdom. Re: Comparative effectiveness of minimally invasive vs open radical prostatectomy. Eur Urol, 57(3), 538.
  30. Lowrance WT, Elkin EB, Jacks LM, Yee DS, Jang TL, Laudone VP, Guillonneau BD, Scardino PT, Eastham JA (2010). Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes. J Urol, 183(4), 1366-72.
  31. Dulabon LM, Lowrance WT, Russo P, Huang WC (2010). Trends in renal tumor surgery delivery within the United States. Cancer, 116(10), 2316-21.
  32. Yee DS, Shariat SF, Lowrance WT, Sterbis JR, Vora KC, Bochner BH, Donat SM, Herr HW, Dalbagni G, Sandhu JS (2010). Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer. J Urol, 183(5), 1751-6.
  33. Lowrance WT, Yee DS, Savage C, Cronin AM, OBrien MF, Donat SM, Vickers A, Russo P (2010). Complications after radical and partial nephrectomy as a function of age. J Urol, 183(5), 1725-30.
  34. Yee DS, Shariat SF, Lowrance WT, Maschino AC, Savage CJ, Cronin AM, Scardino PT, Eastham JA (2010). Prognostic significance of lymphovascular invasion in radical prostatectomy specimens.LID - 10.1111/j.1464-410X.2010.09848.x [doi]. BJU Int.
  35. Boudreaux KJ Jr, Clark PE, Lowrance WT, Rumohr JA, Barocas DA, Cookson MS, Smith JA Jr, Chang SS (2009). Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer. J Urol, 181(2), 540-5; discussion 546.
  36. Thompson RH, Kaag M, Vickers A, Kundu S, Bernstein M, Lowrance W, Galvin D, Dalbagni G, Touijer K, Russo P (2009). Contemporary use of partial nephrectomy at a tertiary care center in the United States. J Urol, 181(3), 993-7.
  37. Boudreaux KJ Jr, Chang SS, Lowrance WT, Rumohr JA, Barocas DA, Cookson MS, Smith JA Jr, Clark PE (2009). Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes. Cancer, 115(4), 770-5.
  38. Lowrance WT, Yee DS, Maschino AC, Cronin AM, Bernstein M, Thompson RH, Russo P (2009). Developments in the surgical management of sporadic synchronous bilateral renal tumours. BJU Int.
  39. Lowrance WT, Rumohr JA, Clark PE, Chang SS, Smith JA Jr, Cookson MS (2009). Urinary diversion trends at a high volume, single American tertiary care center. J Urol, 182(5), 2369-74.
  40. Lowrance WT, Scardino PT (2009). Predictive models for newly diagnosed prostate cancer patients. Rev Urol, 11(3), 117-26.
  41. Lowrance WT, Rumohr JA, Chang SS, Clark PE, Smith JA Jr, Cookson MS (2008). Contemporary open radical cystectomy: analysis of perioperative outcomes. J Urol, 179(4), 1313-8; discussion 1318.
  42. Jung C, DeMarco RT, Lowrance WT, Pope JC 4th, Adams MC, Dietrich MS, Brock JW 3rd (2007). Subureteral injection of dextranomer/hyaluronic acid copolymer for persistent vesicoureteral reflux following ureteroneocystostomy. J Urol, 177(1), 312-5.
  43. Lowrance WT, Cookson MS, Clark PE, Smith JA Jr, Chang SS (2007). Assessing retroperitoneal lymphadenectomy experience in United States urological residency programs. J Urol, 178(2), 500-3; discussion 503.

Review

  1. Lowrance WT, Tarin TV, Shariat SF (2010). Evidence-based comparison of robotic and open radical prostatectomy. [Review]. ScientificWorldJournal, 10, 2228-37.
  2. Lowrance WT, Chang SS, Herrell SD (2006). Primary renal carcinoid tumor managed with laparoscopic partial nephrectomy. [Review]. Urology, 67(3), 622.e19-20.
  3. Lowrance WT, Chang SS (2006). Advancing prostate cancer: treatment options for the urologist. [Review]. Urol Clin North Am, 33(2), 211-7, vii.

Book Chapter

  1. ONeil BB, Lowrance WT (2013). Office-based Bladder of Tumor Fulguration and Surveillance: Indications and Techniques. In Urol Clin North Am (May 2013, 40 (2), pp. 175-82).
  2. Lowrance WT, Sheinfeld J (2011). Radical Orchiectomy and Retropertioneal Lymph Node Dissection. In Comprehensive Textbook of Genitourinary. Lippincott Williams & Wilkins.
  3. Lowrance WT, Chang SS, Cookson MS (2007). Urothelial Carcinoma. In Poston, Beauchamp, Ruers (Ed.), Textbook of Surgical Oncology. Informa Healthcare Medical Books.

Editorial

  1. Lowrance W (2013). discussion. Editorial comment, 189(3), 2203-4.
  2. Lowrance WT, Parekh DJ (2011). The rapid uptake of robotic prostatectomy and its collateral effects.LID - 10.1002/cncr.26275 [doi]. Cancer.
  3. Lowrance WT (2010). Surgical margins following urological cancer surgery and clinical outcomes--does the United States need regional centralization of cancer care? J Urol, 183(6), 2126-7.

Letter

  1. Lowrance WT, Elkin EB, Eastham JA (2010). Minimally invasive vs open radical prostatectomy [Letter to the editor]. JAMA, 303(7), 619-20; author reply 620.

Clinical Trials

Video & News

News

In The News

Video